BP Marsh & Partners PLC - London-based private equity firm, investing in early-stage financial services businesses - Announces up to GBP2 million share buyback to be run by Singer Capital Markets.

The London-based pharmaceutical company said Blenrep, or belantamab mafodotin, was approved for the treatment of adult patients with multiple myeloma in combination with bortezomib plus dexamethasone, ...

(Alliance News) - London's FTSE 100 ended little changed on Thursday, outperforming European peers, as investors weighed an as expected interest rate cut by the European Central Bank.

(Alliance News) - SulNOx Group PLC on Thursday said it has secured a patent covering a further eight countries in Africa from the African Regional Intellectual Property Organization. The London-based ...

(Alliance News) - Franklin Global Trust PLC on Thursday reported a "disappointing" total return during its most recent financial year, falling significantly short of its benchmark, but looks to the ...